top of page

One (1) carton=minimum order. OMIDRIA is sold only in carton quantities. OMIDRIA is not sold in individual vial quantities.

How to order OMIDRIA
NDC#
Unit Quantity
Case Quantity
82604-600-04
One (1) carton contains four (4) single-patient-use vials.
One (1) case contains thirty (30) cartons (120 total vials).
Product
OMIDRIA is supplied in a clear, 5-mL glass, single-patient-use vial containing 4 mL of sterile solution. The smallest sellable unit is a carton, which contains four (4) single-patient-use vials.

ORDER OMIDRIA FOR YOUR FACILITY

OMIDRIA is available through national wholesalers and specialty distributors

OMIDRIA is available through national wholesalers and specialty distributors

*For customers of McKesson full-line wholesaler division, OMIDRIA is available for purchase through McKesson Plasma and Biologics and McKesson Specialty Distribution.

†For customers of Cardinal full-line wholesaler division, OMIDRIA is available for purchase through Cardinal Health Specialty Distribution.

‡For customers of AmerisourceBergen Corporation full-line wholesale division, OMIDRIA is available through AmerisourceBergen specialty distribution and can be ordered using the Passport ordering platform through AmerisourceBergen.

Surgical workflow is maintained with OMIDRIA

Omidria-products-image.png
OMIDRIA dilution and storage¹

Prior to dilution

  • Store at 20ºC to 25ºC (68ºF to 77ºF)

  • Protect from light

Easy to integrate into routine operating procedures

  • Add preoperatively to irrigation solution

    • One 4-mL single-patient-use vial to 500-mL ophthalmic irrigating solution

    • Can be added to irrigation solution in the surgical suite

  • No other preparation required

​

Do not use if the solution is cloudy or contains particulate matter.

After dilution, product can be stored:

  • Up to 4 hours at room temperature

  • Up to 24 hours if refrigerated

REFERENCE:

​

  1. OMIDRIA [package insert]. Bellevue, WA: Rayner Surgical Inc. 2023.

Indications and Usage

OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

Important Safety Information

OMIDRIA must be added to irrigating solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Indications and Usage

OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

Important Safety Information

OMIDRIA must be added to irrigating solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

bottom of page